The Evolution of a Regenerative Medicine Franchise
Kathy McGee, Vice President and General Manager of San Diego’s Advanced BioHealing, Inc. (ABH), will share the story of ABH’s evolution into a multi-million dollar, fully integrated regenerative medicine company. The path which brought ABH to this point differs from how most biotech companies form in that it didn’t begin with a research and development focus, but rather with the purchase of a cell-based technology already approved by the FDA called Dermagraft. Dermagraft is a bio-engineered living skin equivalent used in the treatment of diabetic foot ulcers, and is the focus of an ongoing pivotal trial in subjects with venous leg ulcers (VLUs) to assess the product’s safety and efficacy in the promotion of healing VLUs.
Ms. McGee will discuss Advanced BioHealing’s focus on being the leader in commercializing cell-based technologies, and how that discipline has enabled the production and commercial components of the business to contribute to the Company’s successes in delivering Dermagraft to thousands of patients across the country each year.
About the Presenter
Kathy McGee is Vice President and General Manager at Advanced BioHealing, Inc. (ABH). She joined the Company in May 2006 as Vice President of Operations when ABH purchased global rights to manufacture Dermagraft and TransCyte from Smith & Nephew Wound Management LLC. Ms. McGee served for four years as Director of Manufacturing Operations at Smith & Nephew, and was instrumental in renovating and revalidating the original 70,000 square-foot manufacturing facility in La Jolla, California on behalf of ABH. Prior to joining Smith & Nephew, Ms. McGee began her career at Advanced Tissue Sciences, where she held numerous positions in Manufacturing and Quality Control in the diagnostic test kits business. In 1995, she transitioned to the therapeutic Manufacturing area of the business, where she ultimately held the position as Director of Manufacturing. Ms. McGee has been involved in the biotechnology industry, with a strong focus on tissue engineered medical devices, since 1992. She holds an M.A. in Management from Webster University and a B.S. and Higher Diploma in Education from University College, Galway (Ireland).